2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups IE Lundberg, A Tjärnlund, M Bottai, VP Werth, C Pilkington, M De Visser, ... Arthritis & rheumatology 69 (12), 2271-2282, 2017 | 1378 | 2017 |
Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study RA Evans, H McAuley, EM Harrison, A Shikotra, A Singapuri, M Sereno, ... The Lancet Respiratory Medicine 9 (11), 1275-1287, 2021 | 500 | 2021 |
The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis H Chinoy, N Fertig, CV Oddis, WER Ollier, RG Cooper Annals of the rheumatic diseases 66 (10), 1345-1349, 2007 | 413 | 2007 |
Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study RA Evans, OC Leavy, M Richardson, O Elneima, HJC McAuley, ... The Lancet Respiratory Medicine 10 (8), 761-775, 2022 | 311 | 2022 |
Autoantibodies to a 140‐kd protein in juvenile dermatomyositis are associated with calcinosis H Gunawardena, LR Wedderburn, H Chinoy, ZE Betteridge, J North, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2009 | 264 | 2009 |
2016 American College of Rheumatology/European League Against Rheumatism criteria for minimal, moderate, and major clinical response in adult dermatomyositis and polymyositis … R Aggarwal, LG Rider, N Ruperto, N Bayat, B Erman, BM Feldman, ... Arthritis & Rheumatology 69 (5), 898-910, 2017 | 250* | 2017 |
The EuroMyositis registry: an international collaborative tool to facilitate myositis research JB Lilleker, J Vencovsky, G Wang, LR Wedderburn, LP Diederichsen, ... Annals of the rheumatic diseases 77 (1), 30-39, 2018 | 249 | 2018 |
The role of DMARDs in reducing the immunogenicity of TNF inhibitors in chronic inflammatory diseases M Jani, A Barton, RB Warren, CEM Griffiths, H Chinoy Rheumatology 53 (2), 213-222, 2014 | 249 | 2014 |
Phenotype standardization for statin‐induced myotoxicity A Alfirevic, D Neely, J Armitage, H Chinoy, RG Cooper, R Laaksonen, ... Clinical Pharmacology & Therapeutics 96 (4), 470-476, 2014 | 246 | 2014 |
Clinical associations of autoantibodies to a p155/140 kDa doublet protein in juvenile dermatomyositis H Gunawardena, LR Wedderburn, J North, Z Betteridge, J Dunphy, ... Rheumatology 47 (3), 324-328, 2008 | 241 | 2008 |
Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients Z Betteridge, S Tansley, G Shaddick, H Chinoy, RG Cooper, RP New, ... Journal of autoimmunity 101, 48-55, 2019 | 238 | 2019 |
Clinical and human leucocyte antigen class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target … ZE Betteridge, H Gunawardena, H Chinoy, J North, WER Ollier, ... Annals of the rheumatic diseases 68 (10), 1621-1625, 2009 | 197 | 2009 |
Comparison of three screening tools to detect psoriatic arthritis in patients with psoriasis (CONTEST study) LC Coates, T Aslam, F Al Balushi, AD Burden, E Burden‐The, ... British Journal of Dermatology 168 (4), 802-807, 2013 | 188 | 2013 |
Dense genotyping of immune-related loci in idiopathic inflammatory myopathies confirms HLA alleles as the strongest genetic risk factor and suggests different genetic … S Rothwell, RG Cooper, IE Lundberg, FW Miller, PK Gregersen, J Bowes, ... Annals of the rheumatic diseases 75 (8), 1558-1566, 2016 | 168 | 2016 |
EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a methodology report M Bottai, A Tjärnlund, G Santoni, VP Werth, C Pilkington, M De Visser, ... RMD open 3 (2), e000507, 2017 | 162 | 2017 |
In adult onset myositis, the presence of interstitial lung disease and myositis specific/associated antibodies are governed by HLA class II haplotype, rather than by myositis … H Chinoy, F Salway, N Fertig, N Shephard, BD Tait, W Thomson, ... Arthritis research & therapy 8, 1-9, 2005 | 159 | 2005 |
Genome‐wide association study of dermatomyositis reveals genetic overlap with other autoimmune disorders FW Miller, RG Cooper, J Vencovský, LG Rider, K Danko, LR Wedderburn, ... Arthritis & Rheumatism 65 (12), 3239-3247, 2013 | 158 | 2013 |
Disease specificity of autoantibodies to cytosolic 5′-nucleotidase 1A in sporadic inclusion body myositis versus known autoimmune diseases MK Herbert, J Stammen-Vogelzangs, MM Verbeek, A Rietveld, ... Annals of the rheumatic diseases 75 (4), 696-701, 2016 | 150 | 2016 |
Interaction of HLA-DRB1* 03 and smoking for the development of anti-Jo-1 antibodies in adult idiopathic inflammatory myopathies: a European-wide case study H Chinoy, S Adimulam, F Marriage, P New, M Vincze, E Zilahi, A Kapitány, ... Annals of the rheumatic diseases 71 (6), 961-965, 2012 | 148 | 2012 |
Genome-wide association study identifies HLA 8.1 ancestral haplotype alleles as major genetic risk factors for myositis phenotypes FW Miller, W Chen, TP O'Hanlon, RG Cooper, J Vencovsky, LG Rider, ... Genes & Immunity 16 (7), 470-480, 2015 | 136 | 2015 |